Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

RTS,S

- PMLiVE

AstraZeneca’s Trixeo recommended by CHMP for approval in EU for asthma

Asthma affects over 360 million people worldwide, including over 40 million people in Europe

- PMLiVE

ELRIG appoints Hitesh Sanganee and Marcus Schindler to Scientific Advisory Board

Sanganee and Schindler previously held senior leadership roles at AstraZeneca and Novo Nordisk, respectively

- PMLiVE

A seat at the table: what the EU HTA reforms really ask of patient involvement

The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.

Cuttsy + Cuttsy

- PMLiVE

Pfizer’s Talzenna plus Xtandi gets FDA Priority Review for metastatic prostate cancer

The phase 3 trial showed greater than 50% improvement in radiographic progression-free survival

- PMLiVE

Stoke Therapeutics appoints Thomas McCauley as Chief Scientific Officer

McCauley most recently served as the President and CEO of Neptune Bio

- PMLiVE

Takeda’s zasocitinib shows high rates of skin clearance in phase 3 psoriasis studies

Globally, an estimated 64 million people have psoriasis, with about 80-90% of those having plaque psoriasis

- PMLiVE

Richmond Pharmacology appoints Daniel Chapple as Commercial Director

Chapple has held senior leadership roles at DontBePatient Intelligence, Alira Health, Innovative Trials, Cognizant and ICON

- PMLiVE

Almirall’s paediatric registration of Ebglyss for atopic dermatitis gets EMA acceptance

Atopic dermatitis affects a significant number of children and adolescents and often peaks in childhood

- PMLiVE

The Bloc appoints Jon Chapman as European Executive Creative Director

Chapman previously held senior creative leadership positions at Havas Lynx, BBDO and BBH

- PMLiVE

What do patient stories actually teach us?

How do we translate individual experiences into support that helps others and create support that feels personal but remains relevant to many?

Mednet

- PMLiVE

Lilly to acquire AtaiBeckley in deal worth $2.8bn

The acquisition will advance therapies for treatment-resistant depression and other mental health conditions

- PMLiVE

Camena Bioscience appoints Gregory McGuinness as CEO

McGuinness was most recently CEO at Inanovate

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links